Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegylated Somatropin in Children With Growth Hormone Deficiency
NCT01342146Phase 2Completed
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- May 2006
- Primary completion
- Jan 2007
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of peg-somatropin in growth hormone deficiency (GHD), sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started May 2006; status: completed.
02
Drugs
peg-somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT01342146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01342146.